menu search

: sempra energy’s stock lower premarket after revenue falls short of estimates

Sempra Energy Inc.’s stock SRE fell 3% early Friday, after the energy infrastructure company posted better-than-expected third-quarter profit but re...

November 4, 2023, 4:59 pm

Adobe inc. (adbe) class action: robbins llp reminds investors of lead plaintiff deadline in case against adobe inc.

SAN diego, Nov. 03, 2023 (GLOBE NEWSWIRE) — Robbins LLP reminds investors that a shareholder filed a ...

November 3, 2023, 7:33 pm

Sempra energy's stock lower premarket after revenue falls short of estimates

Sempra Energy Inc.'s stock SRE, +1.88% fell 3% early Friday, after the energy infrastructure company posted better-than-expected third-quarter profit ...

November 3, 2023, 7:24 am

Poolbeg's lead asset to be in the spotlight at leading medical conference

Poolbeg Pharma PLC (AIM:POLB, OTCQB:POLBF) said the potential of its lead asset will be discussed at a leading medical conference in December. A poste...

November 3, 2023, 3:32 am

Shareholder alert: robbins llp informs shareholders of class action filed against barclays plc (bcs)

SAN diego, Nov. 02, 2023 (GLOBE NEWSWIRE) — Robbins LLP informs investors that a shareholder filed a ...

November 3, 2023, 12:46 am

Cidara therapeutics provides corporate update and reports third quarter 2023 financial results

SAN diego, Nov. 02, 2023 (GLOBE NEWSWIRE) — Cidara Therapeutics, Inc. (Nasdaq: CDTX), a biotechnology...

November 2, 2023, 8:15 pm

Greystone provides $15 million in fannie mae financing for multifamily property in san diego, california

NEW YORK, Nov. 02, 2023 (GLOBE NEWSWIRE) — Greystone, a leading national commercial real estate finance company, has provided a $15 million Fannie M...

November 2, 2023, 2:57 pm

Kura oncology and mirati therapeutics enter into clinical collaboration and supply agreement to evaluate ko-2806 and adagrasib in krasᴳ¹²ᶜ-mutated nsclc

– Ongoing Phase 1 dose-escalation trial of KO-2806 (FIT-001) expected to begin dosing patients in combination with adagrasib by mid-2024 – SAN ...

November 2, 2023, 11:30 am

Vincerx pharma to present three posters at ash 2023 in december

VIP943 poster supports selectivity and safety of lead CD123 ADC, VIP943, currently in Phase 1 VIP924 poster shows this novel CXCR5-ADC compares favora...

November 2, 2023, 9:10 am

Centessa pharmaceuticals to present additional 52-weeks of continuous treatment data from third year of ongoing phase 2a study of serpinpc for the treatment of hemophilia at american society of hemato

BOSTON and LONDON, Nov. 02, 2023 (GLOBE NEWSWIRE) -- Centessa Pharmaceuticals plc (Nasdaq: CNTA) today announced that new data from an additional 52-w...

November 2, 2023, 9:09 am

Centessa pharmaceuticals to present additional 52-weeks of continuous treatment data from third year of ongoing phase 2a study of serpinpc for the treatment of hemophilia at american society of hemato

BOSTON and LONDON, Nov. 02, 2023 (GLOBE NEWSWIRE) -- Centessa Pharmaceuticals plc (Nasdaq: CNTA) today announced that new data from an additional 52-w...

November 2, 2023, 9:09 am

Molecular partners to present initial data from ongoing phase 1/2a trial of mp0533 for patients with relapsed/refractory aml and aml/mds at the 65th ash annual meeting and exposition

ZURICH-SCHLIEREN, Switzerland and CONCORD, Mass., Nov. 02, 2023 (GLOBE NEWSWIRE) -- Ad hoc announcement pursuant to Art. 53 LR Molecular Partners AG (...

November 2, 2023, 2:00 am

Gracell biotechnologies to participate in four upcoming investor conferences

SAN diego and SUZHOU, China and SHANGHAI, China, Nov. 01, 2023 (GLOBE NEWSWIRE) -- Gracell Biotechno...

November 1, 2023, 4:00 pm

Ibio further expands tech stack with shieldtx™; enhances immuno-oncology development pipeline with conditionally activated muc16xcd3 bispecific

– ShieldTx potentially increases safety and developability of therapeutic antibodies for difficult targets and modes of action – BRYAN, Texas and ...

November 1, 2023, 12:24 pm

Anaptys announces participation in november investor conferences

SAN diego, Nov. 01, 2023 (GLOBE NEWSWIRE) -- AnaptysBio, Inc. (Nasdaq: ANAB), a clinical-stage biotechn...

November 1, 2023, 9:15 am

Eaf shareholder alert: johnson fistel investigates graftech

SAN diego, Oct. 31, 2023 (GLOBE NEWSWIRE) — Shareholder rights law firm Johnson Fistel, LLP (www.John...

October 31, 2023, 4:20 pm

General atomics congratulates jt60-sa research team on achieving first plasma

World’s largest operational superconducting tokamak achieved milestone on Oct. 23, 2023 San diego, CA...

October 31, 2023, 4:20 pm

Xilio to host virtual investor conference call and webcast on monday, november 6, 2023 to review progress across pipeline, including phase 1/2 clinical data for xtx202, a tumor-activated, engineered,

WALTHAM, Mass., Oct. 31, 2023 (GLOBE NEWSWIRE) -- Xilio Therapeutics, Inc. (Nasdaq: XLO), a clinical-stage biotechnology company discovering and devel...

October 31, 2023, 9:15 am


Search within

Pages Search Results: